NAYA NASDAQ
NAYA Biosciences, Inc.
1W: -9.2%
1M: -7.3%
3M: -61.0%
1Y: -84.0%
3Y: -99.5%
$2.20
Last traded 2025-05-22 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$7M
+116.3% ▲
5Y CAGR: +34.6%
Gross Profit
$3M
+164.6% ▲
5Y CAGR: +16.5%
Operating Income
-$8M
-20.1% ▼
Net Income
-$9M
-13.2% ▼
EPS (Diluted)
$-30.19
-488.4% ▼
EBITDA
-$7M
-3.8% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $1M | $4M | $822K | $3M | $7M |
| YoY Growth | -29.9% | +301.1% | -80.2% | +267.4% | +116.3% |
| Cost of Revenue | $89K | $145K | $851K | $2M | $4M |
| Gross Profit | $949K | $4M | -$29K | $1M | $3M |
| Gross Margin | 91.4% | 96.5% | -3.5% | 36.0% | 44.0% |
| R&D Expenses | $398K | $216K | $544K | $166K | $490K |
| SG&A Expenses | $6M | $9M | $10M | $7M | $9M |
| Operating Expenses | $6M | $9M | $11M | $8M | $11M |
| Operating Income | -$6M | -$5M | -$11M | -$7M | -$8M |
| Operating Margin | -531.7% | -125.4% | -1292.5% | -224.0% | -124.4% |
| Interest Expense | $3M | $1M | $59K | $926K | $1M |
| Income Before Tax | -$8M | -$7M | -$11M | -$8M | -$9M |
| Tax Expense | $36 | $5K | $3K | $28K | -$23K |
| Net Income | -$8M | -$7M | -$11M | -$8M | -$9M |
| Net Margin | -804.7% | -160.0% | -1324.8% | -266.0% | -139.3% |
| EPS (Diluted) | $-15.21 | $-6.26 | $-8.99 | $-5.13 | $-30.19 |
| EBITDA | -$5M | -$5M | -$11M | -$7M | -$7M |
| Shares Outstanding | 1M | 2M | 2M | 3M | 309539 |